Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Quality & Risk

    Use-Related Risk Analysis(URRA)

    In one line
    Analysis of use scenarios to identify potential use errors and their consequences.
    Definition
    A URRA links tasks, potential use errors, and resulting harms - feeding human factors validation testing and ISO 14971 risk control decisions. For each task it records the possible harm and its severity, the risk controls and how they are validated. Tasks where a use error could cause serious harm are critical tasks and must be evaluated in human factors validation testing. FDA's 2022 draft guidance on human factors content in premarket submissions describes the URRA as a key submission element.
    Why it matters
    FDA's human factors guidance expects a documented URRA covering critical tasks, with each tested in summative validation.
    Common pitfalls
    • •Failing to link identified use errors directly to potential harms can lead to an incomplete risk assessment.
    • •Not performing a URRA early enough in the design process can result in costly redesigns and delays.
    • •Assuming that expert users will not make significant use errors can lead to overlooking critical safety issues.
    • •Confusing a Use-Related Risk Analysis with a general risk analysis, which broadens the scope beyond user interaction, can lead to inefficiencies.
    • •Neglecting to update the URRA after design changes or post-market surveillance findings can compromise device safety.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.